Nicholas McGranahan selected as EMBO Young Investigator 2020
1 December 2020
As one of 30 new investigators selected for the prestigious EMBO programme, Dr McGranahan joins a vibrant network of researchers who have "demonstrated scientific excellence and are among the next generation of leading life scientists."
![Nicky McGranahan… Nicky McGranahan…](https://www.ucl.ac.uk/cancer/sites/cancer/files/styles/large_image/public/migrated-images/Nicky-McGranahan.jpg?itok=OqTV0LKj)
Welcoming scientists for over 20 years, the European Molecular Biology Organization (EMBO) Young Investigator programme has a global reputation for excellence. The programme annually identifies and supports some of the most promising early-career life scientists at a critical stage of their careers. EMBO Young Investigators benefit from a variety of financial, training and networking opportunities for them and their lab members over a period of four years.
Researchers chosen for the programme are selected for their outstanding scientific acheivements.
Nicholas McGranahan leads the UCL Cancer Genome Evolution Research Group and co-leads the bioinformatics within the CRUK-UCL Lung Cancer Centre of Excellence and TRACERx team at UCL. The team's research is focused on using computational methods to explore the cancer development and anti-tumour immunity within an evolutionary framework. By looking into how cancers evolve, the Group have recently explored the importance of large-scale gross chromosomal aberrations in cancer, identifying consistent patterns across tumours and also uncovering the importance of whole-genome duplications to buffer harmful alterations.
Speaking of the annoucement, Dr McGranahan said: "I feel incredibly honoured to be selected as one of this year's Young Investigators – it is really a testament to the hard work of my team and our wonderful collaborators. I'm very much looking forward to being a part of the EMBO scientific community and the opportunities to develop our work."
Further information
- EMBO press release: EMBO welcome thirty Young Investigators
- Cancer Genome Evolution Research Group - Dr Nicholas McGranahan
- Cancer Evolution and Genome Instability Lab - Prof Charles Swanton
- CRUK Lung Cancer Centre of Excellence
- TRACERx (TRAcking Cancer Evolution through therapy (Rx))
- CRUK City of London Centre
Cancer’s ‘genome doubling’ mystery solved
![Cancer’s ‘genome doubling’ mystery solved Cancer Cells](https://www.ucl.ac.uk/cancer/sites/cancer/files/styles/small_image/public/cancer_cells_crop.jpg?itok=ABnVgBvD)
Researchers at the Francis Crick Institute and UCL have established why some cancer cells exhibit an unusual phenomenon called whole genome doubling, where every chromosome is duplicated.